Soru

Zorluk: ZorInfectious Diseases

A 6868-year-old man is evaluated in the intensive care unit for a new-onset fever and increased respiratory secretions. He has been receiving mechanical ventilation for 77 days following a severe cerebrovascular accident. His temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 110/70 mmHg110/70\text{ mmHg}, and pulse is 105/min105/\text{min}. Physical examination reveals coarse crackles in the right lower lung field. A chest radiograph demonstrates a new right lower lobe infiltrate. Endotracheal aspiration is performed, and empiric intravenous therapy with cefepime, tobramycin, and vancomycin is initiated.

Forty-eight hours later, the patient's temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}) and his oxygenation has steadily improved. The endotracheal aspirate culture grows 106 CFU/mL10^6\text{ CFU/mL} of *Pseudomonas aeruginosa*. Antimicrobial susceptibility testing indicates the organism is susceptible to cefepime, meropenem, and tobramycin, but resistant to levofloxacin. No other organisms are isolated. Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

  1. A
    Discontinue vancomycin, and continue cefepime and tobramycin
  2. B
    Discontinue the current regimen and initiate meropenem
  3. Discontinue vancomycin and tobramycin, and continue cefepimeCevap
  4. D
    Continue vancomycin, cefepime, and tobramycin
  5. E
    Discontinue tobramycin, and continue cefepime and vancomycin

Cevap

Discontinue vancomycin and tobramycin, and continue cefepime
The most appropriate next step is to discontinue vancomycin and tobramycin, and continue cefepime as monotherapy. This patient was appropriately started on broad-spectrum empiric therapy for ventilator-associated pneumonia (VAP), which commonly includes coverage for MRSA (vancomycin) and double coverage for *Pseudomonas aeruginosa* (cefepime and tobramycin). However, once culture results are available and the patient demonstrates clinical improvement, antimicrobial stewardship principles dictate rapid de-escalation. Because the endotracheal aspirate culture did not grow MRSA, vancomycin should be stopped. Furthermore, routine definitive double-coverage for *Pseudomonas* is not recommended. Once the isolate is confirmed to be susceptible to an active beta-lactam (cefepime), the second antipseudomonal agent (tobramycin) should be discontinued to minimize unnecessary nephrotoxicity and ototoxicity.

Adım Adım Çözüm

1
Evaluate the patient's clinical response to the empiric antimicrobial therapy.
The patient's fever has resolved (37.2∘C37.2^\circ\text{C}) and his oxygenation has improved, indicating clinical stability and a positive response to the current regimen.
Clinical stability dictates whether de-escalation is safe; deteriorating patients may require broader or alternative coverage.
2
Analyze the microbiological culture and susceptibility results.
The culture isolated only *Pseudomonas aeruginosa*, which is susceptible to cefepime. No Methicillin-resistant *Staphylococcus aureus* (MRSA) was grown.
Definitive culture data allows the medical team to target the specific pathogen and safely remove unnecessary broad-spectrum agents.
3
Modify the antimicrobial regimen based on standard stewardship guidelines for ventilator-associated pneumonia (VAP).
Vancomycin is discontinued due to the absence of MRSA, and tobramycin is discontinued because dual coverage for *Pseudomonas* is no longer indicated. Cefepime is continued as targeted monotherapy.
Once susceptibility to an active beta-lactam is confirmed in a responding patient, continuing a second antipseudomonal agent (like an aminoglycoside) only adds toxicity without improving clinical outcomes.

Anahtar Kavram

Antimicrobial de-escalation in ventilator-associated pneumonia (VAP) involves transitioning from broad-spectrum empiric therapy (MRSA coverage + double antipseudomonal coverage) to targeted monotherapy based on culture susceptibilities and clinical improvement.
Tahmini Süre:1m 30s
Bu soruyu puanla